Bruce C. Doeg

Represented a transformative health IT company from formation to sale to a Fortune 10 company.

Represented the acquiror of an Indian technology company.

Represented a genetics/diagnostics company in its sale to a public company.

Representing a clinical lab in connection with its sale.

Represented the acquiror of a UK company that developed technology for high speed, high frequency stock trading.

Represented the acquiror of a provider of services to the convenience store industry.

Represented the acquiror of the assets of Elvis Presley Enterprises.

Represented a leading website development company for automobile dealers in its sale to a publicly traded purchaser.

Represented a Fortune 50 company in the divestiture of a technology subsidiary.

Represented an HIT payments company in its sale to a strategic acquirer.

Representing a contract manufacturer with cross-border operations in the sale of company. 

Represented a nationally known consumer products company in the sale of the assets of a subsidiary containing key brands.

Represented a family car wash business in the sale of multiple locations to a global car wash company for more than $100 million.

Served as the government contracts counsel for the negotiation of an asset sale on behalf of two sister pharmaceutical companies. The purchaser was a buyer affiliated with and funded by a Chinese entity. Assets sold consisted of realty and personalty in Kentucky and Puerto Rico, and purchase price, including tax credits and earnouts, equaled $36 million. Representation involved the assignment of contracts with state and federal government agencies, the negotiation of a novation agreement and other assignment agreements, and other regulatory and compliance matters.

Represented a multi-therapeutic clinical research "super site" facility in a stock sale to a private equity firm for $75 million.

Representing a publicly traded company in the cancer diagnostic space in contracts and acquisitions.

Representing a genetics/diagnostics company in a joint venture with a publicly traded Australian company.

Representing a Fortune 50 health care device company with its technology agreements.

Representing an electric battery manufacturer in its contract, financing and corporate needs.

Representing an IP owner and developer of saline-cooled small modular nuclear reactors in capital formation, contracts, joint ventures and corporate governance.

Providing outside general counsel services, including all contracts, to the U.S. subsidiary of a global services company.

Represented an HIT company in its expansion to the UK.

Represented a hospital system in outsourcing its IT department.

Represented a publicly traded biotechnology company in an internal investigation.

Represented a publicly traded technology company in an internal investigation. 

Represented a Fortune 50 company in an outsourcing of software development and implementation project to an Indian company.

Represented a technology company in dealings with the Federal Trade Commission arising out of a computer hacking incident leading to possible dissemination of personal information.

Represented a data analytics company in an FTC investigation.

Represented a technology company in developing its open source software strategy.

Served as corporate counsel for a large, publicly traded manufacturer, a large private distributor, a generic pharmaceutical company, a fiber optics company, and a leading emerging company in the electronic health records field.

Served as corporate and board counsel to a non-profit foundation focused on education and protection of First Amendment principles.

Served as corporate and board counsel for an independent oil and gas company, an emerging biotechnology firm, a medical device company and a health information technology company.